Rodríguez CMA, Martínez MI, Velarde LDA, Cabrera JR, Díaz GEJ, Rodríguez WF

Language: Spanish
References: 20
Page: 208-216
PDF size: 222.03 Kb.

ABSTRACT

Introduction: quality indicators are clinical tools used to measure and qualify therapeutic interventions objectively. Objective: this study aims to measure previously established and validated quality indicators (QI) evaluating in-hospital treated urinary tract infections (UTI). Material and methods: this was a consecutive patient, observational, retrospective, descriptive, open clinical study. During two years, we assessed the adherence to eight QI, evaluating the empiric antimicrobial treatment and diagnostic follow-up of in-hospital treated adults diagnosed with community-acquired UTI. Results: a total of 78 cases were evaluated; a performance of 89.7% was observed for culture obtention, along a 46.2 and 48.7% national and international treatment guideline compliance, respectively. It is noted that a low compliance index was pointed out for the clinical condition-guided and microbiological study-guided treatment adjustment items (18.3-31.3% y 28.2-48.27%) but were probably impacted by the short in-hospital-stay average, which was < 72 h in 62% of the cases. Other indicators were deemed poorly assessable, such as selective quinolone use, urinary catheter exchange, renal function adjustment, and plasma concentration-guided adjustment. Conclusions: we conclude that comparing similar reports, QI compliance for community-acquired UTI treated in our institution is identical; nevertheless, there is still room for improvement concerning therapy adjustment practices.

REFERENCES

1. Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019; 11: 1756287219832172.

2. Spoorenberg V, Geerlings SE, Geskus RB, De Reijke T, Prins J, Hulscher M. Appropriate antibiotic use for patients with complicated urinary tract infections in 38 Dutch Hospital Departments: a retrospective study of variation and determinants. BMC infectious diseases. 2015; 15 (1): 1-9.

3. Van den Bosch CM, Geerlings SE, Natsch S, Prins JM, Hulscher ME. Quality indicators to measure appropriate antibiotic use in hospitalized adults. Clinical Infect Dis. 2015; 60 (2): 281-291.

4. Arcenillas P, Boix-Palop L, Gómez L, Xercavins M, March P, Martinez L et al. Assessment of quality indicators for appropriate antibiotic use. Antimicrob Agents Chemother. 2018; 62 (12): e00875-00918.

5. Hermanides HS, Hulscher ME, Schouten JA, Prins JM, Geerlings SE. Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: a first step to measure and improve care. Clin Infect Dis. 2008; 46 (5): 703-711.

6. Dyar OJ, Beovic B, Pulcini C, Tacconelli E, Hulscher M, Cookson B et al. ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus. Clin Microbiol Infect. 2019; 25 (1): 13-19.

7. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010; 50 (5): 625-663.

8. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011; 52 (5): e103-120.

9. Bonkat G, Pickard R, Bartoletti R, Bruyère F, Geerlings S, Wagenlehner F et al. EAU guidelines on urological infections. European Association of Urology. 2019; 18: 22-26.

10. Guía de Práctica Clínica Diagnóstico y Tratamiento de la Pielonefritis Aguda no Complicada en el Adulto México: Secretaría de Salud; 2014.

11. De Referencia Rápida G. Diagnóstico y tratamiento de la infección aguda, no complicada del tracto urinario en la mujer. Guía de Práctica Clínica IMSS-077-08.

12. Prevención, diagnóstico y tratamiento de la infección del tracto urinario bajo en el primer nivel de atención México: Instituto Mexicano del Seguro Social; 2016.

13. Van den Bosch C, Hulscher ME, Akkermans RP, Wille J, Geerlings SE, Prins JM. Appropriate antibiotic use reduces length of hospital stay. J Antimicrob Chemother. 2017; 72 (3): 923-932.

14. Rodríguez-Cervera MA, Castañeda-Mendez PF, Soto-Ramírez L, Cabrera-Ruiz L et al. Adherence to international empiric antibiotic treatment guidelines in a tertiary teaching hospital in Mexico City. Open Forum Infectious Diseases. 2016; 3 (Suppl 1): 961.

15. Spoorenberg V, Hulscher ME, Akkermans RP, Prins JM, Geerlings SE. Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay. Clin Infect Dis. 2014; 58 (2): 164-169.

16. Chardavoyne PC, Kasmire KE. Appropriateness of antibiotic prescriptions for urinary tract infections. West J Emerg Med. 2020; 21 (3): 633-639.

17. Spoorenberg V, Hulscher ME, Geskus RB, de Reijke TM, Opmeer BC, Prins JM et al. A cluster-randomized trial of Two strategies to improve antibiotic use for patients with a complicated urinary tract infection. PloS One. 2015; 10 (12): e0142672.

18. Kiyatkin D, Bessman E, McKenzie R. Impact of antibiotic choices made in the emergency department on appropriateness of antibiotic treatment of urinary tract infections in hospitalized patients. J Hosp Med. 2016; 11 (3): 181-184.

19. Schuts EC, Hulscher M, Mouton JW, Verduin CM, Stuart J, Overdiek H et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016; 16 (7): 847-856.

20. Bader MS, Hawboldt J, Brooks A. Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2010; 122 (6): 7-15.